BCL2 and gastric cancer: The results also indicated that the ratio of Bcl-2 to Bax was considerably lowered in Ginsenoside Rg3-stimulated GC cells which were pre-treated with cisplatin (p < 0.001, Figure 6C), indicating the apoptotic effects of Ginsenoside Rg3 on cisplatin-resistant GC cells.